vs
ABVC BIOPHARMA, INC.（ABVC）与INTRUSION INC（INTZ）财务数据对比。点击上方公司名可切换其他公司
INTRUSION INC的季度营收约是ABVC BIOPHARMA, INC.的1.9倍（$1.5M vs $796.0K），INTRUSION INC净利率更高（-190.7% vs -256.6%，领先65.9%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -11.6%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs 14.4%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
因创思公司（Intrusion Inc.）是一家总部位于得克萨斯州普莱诺的网络安全企业，主营网络安全解决方案业务，核心产品包含网络入侵检测与防御系统，为各类型客户的网络空间安全运营提供专业保障。
ABVC vs INTZ — 直观对比
营收规模更大
INTZ
是对方的1.9倍
$796.0K
营收增速更快
ABVC
高出116.1%
-11.6%
净利率更高
INTZ
高出65.9%
-256.6%
两年增速更快
ABVC
近两年复合增速
14.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $1.5M |
| 净利润 | $-2.0M | $-2.8M |
| 毛利率 | 100.0% | 74.3% |
| 营业利润率 | -246.8% | -192.4% |
| 净利率 | -256.6% | -190.7% |
| 营收同比 | 104.5% | -11.6% |
| 净利润同比 | -417.4% | -44.4% |
| 每股收益（稀释后） | $-0.09 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCINTZ
| Q4 25 | — | $1.5M | ||
| Q3 25 | $796.0K | $2.0M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | $2.0K | $1.7M | ||
| Q3 24 | $389.3K | $1.5M | ||
| Q2 24 | $117.1K | $1.5M | ||
| Q1 24 | $1.2K | $1.1M |
净利润ABVCINTZ
| Q4 25 | — | $-2.8M | ||
| Q3 25 | $-2.0M | $-2.1M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | $-394.8K | $-2.0M | ||
| Q2 24 | $-942.3K | $-2.1M | ||
| Q1 24 | $-2.8M | $-1.7M |
毛利率ABVCINTZ
| Q4 25 | — | 74.3% | ||
| Q3 25 | 100.0% | 76.6% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 75.7% | ||
| Q4 24 | 100.0% | 74.9% | ||
| Q3 24 | 99.9% | 77.1% | ||
| Q2 24 | 99.8% | 76.0% | ||
| Q1 24 | 77.0% | 80.0% |
营业利润率ABVCINTZ
| Q4 25 | — | -192.4% | ||
| Q3 25 | -246.8% | -108.6% | ||
| Q2 25 | — | -111.4% | ||
| Q1 25 | — | -117.9% | ||
| Q4 24 | — | -113.5% | ||
| Q3 24 | -77.7% | -135.5% | ||
| Q2 24 | -734.2% | -139.2% | ||
| Q1 24 | -235539.8% | -218.6% |
净利率ABVCINTZ
| Q4 25 | — | -190.7% | ||
| Q3 25 | -256.6% | -106.5% | ||
| Q2 25 | — | -109.0% | ||
| Q1 25 | — | -118.2% | ||
| Q4 24 | — | -116.8% | ||
| Q3 24 | -101.4% | -136.3% | ||
| Q2 24 | -804.4% | -141.6% | ||
| Q1 24 | -235203.2% | -151.7% |
每股收益（稀释后）ABVCINTZ
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.09 | $-0.10 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.11 | ||
| Q4 24 | — | $0.19 | ||
| Q3 24 | $-0.03 | $-0.35 | ||
| Q2 24 | $-0.08 | $-0.53 | ||
| Q1 24 | $-0.29 | $-0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $3.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $7.3M |
| 总资产 | $21.2M | $10.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCINTZ
| Q4 25 | — | $3.6M | ||
| Q3 25 | $257.2K | $4.5M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $10.7M | ||
| Q4 24 | $313.1K | $4.9M | ||
| Q3 24 | $208.2K | $1.1M | ||
| Q2 24 | $200.0K | $1.5M | ||
| Q1 24 | $106.4K | $122.0K |
股东权益ABVCINTZ
| Q4 25 | — | $7.3M | ||
| Q3 25 | $12.1M | $9.8M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $13.4M | ||
| Q4 24 | $1.2M | $6.3M | ||
| Q3 24 | $1.6M | $2.6M | ||
| Q2 24 | $1.8M | $2.9M | ||
| Q1 24 | $1.7M | $-1.2M |
总资产ABVCINTZ
| Q4 25 | — | $10.4M | ||
| Q3 25 | $21.2M | $13.7M | ||
| Q2 25 | — | $16.4M | ||
| Q1 25 | — | $18.0M | ||
| Q4 24 | $7.5M | $11.5M | ||
| Q3 24 | $7.8M | $7.4M | ||
| Q2 24 | $8.0M | $7.5M | ||
| Q1 24 | $8.0M | $5.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-531.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-549.0K |
| 自由现金流率自由现金流/营收 | — | -37.1% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-7.5M |
8季度趋势，按日历期对齐
经营现金流ABVCINTZ
| Q4 25 | — | $-531.0K | ||
| Q3 25 | $-964.7K | $-3.0M | ||
| Q2 25 | — | $-1.6M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | $-1.8M | $-178.0K | ||
| Q3 24 | $60.2K | $-2.1M | ||
| Q2 24 | $-211.4K | $-2.9M | ||
| Q1 24 | $-955.8K | $-1.1M |
自由现金流ABVCINTZ
| Q4 25 | — | $-549.0K | ||
| Q3 25 | — | $-3.0M | ||
| Q2 25 | — | $-1.9M | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $-645.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | — | $-1.2M |
自由现金流率ABVCINTZ
| Q4 25 | — | -37.1% | ||
| Q3 25 | — | -153.2% | ||
| Q2 25 | — | -101.1% | ||
| Q1 25 | — | -117.3% | ||
| Q4 24 | — | -38.5% | ||
| Q3 24 | — | -140.4% | ||
| Q2 24 | — | -202.3% | ||
| Q1 24 | — | -104.2% |
资本支出强度ABVCINTZ
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 22.1% | ||
| Q4 24 | — | 27.9% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 5.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
